Xiuling Li

Efficacy and Safety of Ivarmacitinib in Patients with Moderate-to-Severe, Active, Ulcerative Colitis: A Phase II Study.

Fei Liu, D. Rubin, Minhu Chen, 2022, Gastroenterology.

Concurrent silencing of TBCE and drug delivery to overcome platinum-based resistance in liver cancer

Wende Li, P. Saw, Lei Zhang, 2022, Acta pharmaceutica Sinica. B.